Neuromuscular Electrical Stimulation in Chronic Low Back Pain

NCT04119895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-04-23

No results posted yet for this study

Summary

This study evaluates whether there is additive effect of neuromuscular electrical stimulation applied to lower lumbar region to core stabilization exercises in the management of chronic low back pain. Participants will randomly divide into two groups; half will receive core stabilization exercises and neuromuscular electrical stimulation (NMES) in combination, while the other half will receive core stabilization exercises and sham NMES.

Conditions

  • Low Back Pain

Interventions

OTHER

Neuromuscular electrical stimulation and core stabilization exercise

In NMES group, the amplitude of the electrical current will be set at the highest level subject can tolerate. The lumbar stabilization mode of the device will be used. This mode consists of three phases; warming, contraction and recovery phases. The duration will be set to 35 minutes. In the first 2 minutes (warming phase), frequency is 6 Hz. Contraction phase includes consecutive cycles of contractile frequency of 40 Hz for 6 seconds and the rest frequency of 4 Hz for 12 seconds, lasting a total of 30 minutes. The last 3 minutes (recovery phase) frequency is 3 Hz. The ramp up time is 2 seconds and the ramp down time is 1 second

OTHER

Sham neuromuscular electrical stimulation and core stabilization exercise

In sham NMES group, the amplitude of the electrical current will be set at a minimum level which does not stimulate any contraction.

Sponsors & Collaborators

  • Bahçeşehir University

    collaborator OTHER
  • Koç University

    lead OTHER

Principal Investigators

  • Ozden Ozyemisci Taskiran, Prof · Koc University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-16
Primary Completion
2019-10-16
Completion
2019-10-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04119895 on ClinicalTrials.gov